Abstract:The advent of serial crystallography has rejuvenated and popularized room-temperature X-ray crystal structure determination. Structures determined at physiological temperature reveal protein flexibility and dynamics. In addition, challenging samples (e.g. large complexes, membrane proteins and viruses) form fragile crystals that are often difficult to harvest for cryo-crystallography. Moreover, a typical serial crystallography experiment requires a large number of microcrystals, mainly achievable through batch crystallization. Many medically relevant samples are expressed in mammalian cell lines, producing a meager quantity of protein that is incompatible with batch crystallization. This can limit the scope of serial crystallography approaches. Direct in situ data collection from a 96-well crystallization plate enables not only the identification of the best diffracting crystallization condition but also the possibility for structure determination under ambient conditions. Here, we describe an in situ serial crystallography (iSX) approach, facilitating direct measurement from crystallization plates mounted on a rapidly exchangeable universal plate holder deployed at a microfocus beamline, ID23-2, at the European Synchrotron Radiation Facility. We applied our iSX approach on a challenging project, autotaxin, a therapeutic target expressed in a stable human cell line, to determine the structure in the lowest-symmetry P1 space group at 3.0 Å resolution. Our in situ data collection strategy provided a complete dataset for structure determination while screening various crystallization conditions. Our data analysis reveals that the iSX approach is highly efficient at a microfocus beamline, improving throughput and demonstrating how crystallization plates can be routinely used as an alternative method of presenting samples for serial crystallography experiments at synchrotrons.

Artificial intelligence to solve the X-ray crystallography phase problem: a case study report

AlphaFold-assisted structure determination of a bacterial protein of unknown function using X-ray and electron crystallography

Best Practices of Using AI-Based Models in Crystallography and Their Impact in Structural Biology

PhAI: A deep learning approach to solve the crystallographic phase problem

Protein Structure Determination Using a Riemannian Approach

In situ serial crystallography facilitates 96-well plate structural analysis at low symmetry

AI-Based Protein Structure Prediction in Drug Discovery: Impacts and Challenges

A New Route for the Determination of Protein Structure and Function

CrysFormer: Protein structure determination via Patterson maps, deep learning, and partial structure attention

The success rate of processed predicted models in molecular replacement: implications for experimental phasing in the AlphaFold era

A New Route for the Determination of Protein Structure in Physiological Environment

Crystallography companion agent for high-throughput materials discovery

Assessment of AI-Based Protein Structure Prediction for the NLRP3 Target

Towards end-to-end structure determination from x-ray diffraction data using deep learning

CrystalX: Ultra-Precision Crystal Structure Resolution and Error Correction Using Deep Learning

AlphaFold 2 and NMR Spectroscopy: Partners to Understand Protein Structure, Dynamics and Function

Analysis of Three-Dimensional Protein Images

Optimal atomic-resolution structures of prion AGAAAAGA amyloid fibrils

A modified phase-retrieval algorithm to facilitate automatic de novo macromolecular structure determination in single-wavelength anomalous diffraction

Cracking AlphaFold2: Leveraging the power of artificial intelligence in undergraduate biochemistry curriculums

Novel Artificial Intelligence-Based Approaches for Ab Initio Structure Determination and Atomic Model Building for Cryo-Electron Microscopy